【摘要】 目的分析本地区孕产妇血清不规则抗体阳性率的最新动态。方法选取我院收诊的420例输血孕产妇作为研究对象,按孕产史及输血史的差别分为A组(2次及以上)和B组(无或小于2次),输血前按输血规范要求进行不规则抗体的检测,统计不规则抗体的阳性率,进一步比较分析A组和B组阳性率的差异。结果 420例输血孕产妇共检出阳性不规则抗体6例,检出率是1.43%,其中有孕产史及输血史A组的阳性率(2.13%)高于无孕产史及输血史B组的阳性率(0.86%)对比差异有统计学意义(P<0.05)。结论孕产妇群体的输血不规抗体阳性率相对普通输血人群要高,且有多次孕产或输血史的不规则抗体的阳性率会更高,因此临床输血对孕产妇群体相关检查需高度重视。更多还原

【Abstract】 Objective To analyze the latest trends of the positive rate of irregular antibody in maternal serum in this region. Methods 420 cases of pregnant and postpartum women with blood transfusion who were treated in our hospital were selected as subjects. According to the difference of pregnancy and blood transfusion history, they were divided into two groups: group A(2 times or more) and group B(no or less than 2 times). Results 420 cases were detected positive 6 cases, irregular antibody detection rate is 1.43%, the positive rate of group A(2.13%) than the positive rate of group B(0.86%), with significant difference(P<0.05). Conclusion Maternal group blood transfusion is not gauge the antibody positive rate is higher than general transfusion patients, and has A history of multiple maternal or blood transfusion irregular antibody positive rate will be higher, so the clinical blood transfusion on maternal group related inspection should be highly valued.更多还原